For example, treatment of tumor-bearing mice with NS-398 (COX-2 inhibitor), to reduce prostaglandin synthesis of tumor cells, can enhance the transcription factor Zbtb46, induce cDC lineage maturation, and enhance the activity of DCs [124–126]. Here, ZBTB46 is linked to neoplasm.